COMPOSITIONS AND METHODS FOR ASSAY MEASUREMENTS

    公开(公告)号:US20230279290A1

    公开(公告)日:2023-09-07

    申请号:US18145735

    申请日:2022-12-22

    CPC classification number: C09K11/02 C12Q1/6816

    Abstract: The disclosure relates to novel compositions comprising an electrochemiluminescence (ECL) co-reactant. In embodiments, the composition further comprises an ionic component, a surfactant, or combination thereof. In embodiments, the ECL co-reactant is triethanolamine (TEA), tert-butyldiethanolamine (tBDEA), methyldibutylethanolamine (MDEA), 3-[Bis-(2-hydroxy-ethyl)-amino]-propane-1-sulfonic acid (DEA-PS), or a combination thereof. Methods of using the compositions and kits comprising the compositions are also provided herein, including methods using ECL-labeled oligonucleotide probes having quenching moieties.

    GLOMERULONEPHRITIS BIOMARKERS
    4.
    发明申请
    GLOMERULONEPHRITIS BIOMARKERS 审中-公开
    GLOMERULONEPHRITIS生物标志物

    公开(公告)号:US20140221325A1

    公开(公告)日:2014-08-07

    申请号:US14168688

    申请日:2014-01-30

    CPC classification number: G01N33/6893 G01N2800/347 G01N2800/52

    Abstract: The present invention relates to methods of diagnosing glomerulonephritis (GN) in a patient, as well as methods of monitoring the progression of GN and/or methods of monitoring a treatment protocol of a therapeutic agent or a therapeutic regimen. The invention also relates to assay methods used in connection with the diagnostic methods described herein.

    Abstract translation: 本发明涉及诊断患者的肾小球肾炎(GN)的方法以及监测GN进展的方法和/或监测治疗剂或治疗方案的治疗方案的方法。 本发明还涉及结合本文所述的诊断方法使用的测定方法。

Patent Agency Ranking